Literature DB >> 22340241

Proteomic analysis identifies translationally controlled tumor protein as a mediator of phosphatase of regenerating liver-3-promoted proliferation, migration and invasion in human colon cancer cells.

Zhong-Hua Chu1, Lu Liu, Chao-Xu Zheng, Wei Lai, Shou-Feng Li, Heng Wu, Yu-Jie Zeng, Hai-Yan Zhao, Yu-Feng Guan.   

Abstract

BACKGROUND: Considerable evidence suggests that phosphatase of regenerating liver-3 (PRL-3) plays multiple roles in cancer metastasis; however, the molecular mechanisms remain largely unknown. The aim of this study was to identify proteins associated with PRL-3-promoted colon cancer metastasis, by comparative proteomic analysis.
METHODS: Proteomes of human colon cancer LoVo cells transfected with PRL-3 gene (LoVo-PRL-3) or empty vector PAcGFP-C3 (LoVo-control) were compared using 2D gel electrophoresis. Proteins that varied significantly in concentration were selected and identified using mass spectrometry. Expression of translationally controlled tumor protein (TCTP) mRNA and protein in LoVo-PRL-3 and LoVo-control cells was detected by real-time PCR and Western blotting. Small interfering RNA (siRNA) targeting TCTP was used for silencing TCTP expression in LoVo-PRL-3 cells. Functional significance of TCTP in PRL-3-promoted colon cancer cell proliferation, migration and invasion was investigated by Cell Counting Kit-8 assay and transwell chamber.
RESULTS: Seventeen proteins displaying significant and reproducible differences between LoVo-PRL-3 and LoVo-control cells were identified. Ten proteins were upregulated and seven were downregulated in LoVo-PRL-3 cells when compared with LoVo-control cells. Eight identified proteins are associated with distinct steps of tumor metastasis: ubiquitin-like protein ISG15, interleukin-18, TCTP, serpin B5, annexin A3, macrophage-capping protein, ATP-dependent RNA helicase DDX3X, and cathepsin D. Real-time PCR and Western blotting results showed that both TCTP mRNA and protein were significantly increased in LoVo-PRL-3 cells compared to LoVo-control cells. Transfection with TCTP siRNA significantly reduced the expression of both mRNA and protein levels of TCTP in LoVo-PRL-3 cells. Knockdown of TCTP by siRNA inhibited PRL-3-promoted proliferation, migration and invasion of LoVo-PRL-3 cells.
CONCLUSION: Our results imply that TCTP might be a mediator of PRL-3-promoted proliferation, migration and invasion of human colon cancer cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22340241

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  5 in total

Review 1.  Translationally controlled tumor protein: the mediator promoting cancer invasion and migration and its potential clinical prospects.

Authors:  Junying Gao; Yan Ma; Guiwen Yang; Guorong Li
Journal:  J Zhejiang Univ Sci B       Date:  2022-08-15       Impact factor: 5.552

2.  Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor.

Authors:  Rui Huang; Guiyu Wang; Yanni Song; Qingchao Tang; Qi You; Zheng Liu; Yinggang Chen; Qian Zhang; Jiaying Li; Shan Muhammand; Xishan Wang
Journal:  Mol Med Rep       Date:  2015-04-28       Impact factor: 2.952

3.  Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin.

Authors:  Ulrich-Axel Bommer; Kara L Vine; Prianka Puri; Martin Engel; Lisa Belfiore; Karen Fildes; Marijka Batterham; Alistair Lochhead; Morteza Aghmesheh
Journal:  Cell Commun Signal       Date:  2017-02-01       Impact factor: 5.712

4.  HpSlyD inducing CDX2 and VIL1 expression mediated through TCTP protein may contribute to intestinal metaplasia in the stomach.

Authors:  Qiuping Li; Yanmei Zhu; Jun Liu; Xiuwen Yu; Moye Chen; Nannan Dong; Yuehua Gong; Yuan Yuan
Journal:  Sci Rep       Date:  2017-05-23       Impact factor: 4.379

5.  RNA interference‑mediated knockdown of translationally controlled tumor protein induces apoptosis, and inhibits growth and invasion in glioma cells.

Authors:  Hua Jin; Xuexin Zhang; Jun Su; Yueqiu Teng; Huan Ren; Lizhuang Yang
Journal:  Mol Med Rep       Date:  2015-09-02       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.